NCT01328652View on ClinicalTrials.gov

Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy

PHASE4UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

January 31, 2013

Conditions
Laryngopharyngeal RefluxHypertrophy of Lingual Tonsil
Interventions
DRUG

dexlansoprazole

dexlansoprazole 60 mg once daily for 3 months

Trial Locations (1)

60657

Advanced Center for Specialty Care, Chicago

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Advanced Center for Specialty Care

OTHER

NCT01328652 - Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy | Biotech Hunter | Biotech Hunter